MXCT
MAXCYTE, INC.
NASDAQ · Healthcare · Medical - Devices · US
$1.19
−0.42%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- -$0.08
- Revenue estimate
- $7.0M
Latest reported
- Last report date
- Aug 12, 2026
- EPS actual
- -$0.08
- EPS estimate
- -$0.09
- Revenue actual
- $7.3M
- Revenue estimate
- $6.5M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 3
- Avg surprise (4Q)
- +21.8%
- Revenue beats (12Q)
- 8
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 12, 2026 | -$0.09 | -$0.08 | Beat 11.11% | $7.3M |
| May 12, 2026 | -$0.10 | -$0.04 | Beat 60.00% | $9.7M |
| Mar 24, 2026 | -$0.08 | -$0.06 | Beat 25.00% | $7.3M |
| Nov 12, 2025 | -$0.11 | -$0.12 | Miss -9.09% | $6.8M |
| Aug 6, 2025 | -$0.10 | -$0.12 | Miss -20.00% | $8.5M |
| May 7, 2025 | -$0.10 | -$0.10 | In line | $10.4M |
| Mar 11, 2025 | -$0.12 | -$0.10 | Beat 16.67% | $8.7M |
| Mar 12, 2024 | -$0.10 | -$0.05 | Beat 50.00% | $15.7M |
| Mar 15, 2023 | -$0.06 | -$0.05 | Beat 16.67% | $12.4M |
| Nov 9, 2022 | -$0.09 | -$0.06 | Beat 33.33% | $10.6M |
| Aug 10, 2022 | -$0.08 | -$0.08 | In line | $9.6M |
| Mar 22, 2022 | -$0.05 | -$0.05 | In line | $10.2M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026